福建博悦医药科技

Fujian Boyue Pharmaceutical Technology Co., Ltd. (福建博悦医药科技有限公司) is a Chinese pharmaceutical company established in December 2022 as a subsidiary of Shanghai Boyue Biotechnology Co., Ltd. Located in Mingxi County, Fujian Province, the company operates a comprehensive drug Marketing Authorization Holder (MAH) platform and a GSP-certified drug distribution platform. It bridges the gap between Shanghai-based R&D and local industrialization, offering end-to-end services from high-barrier formulation development and registration to contract manufacturing and wholesale distribution. Fujian Boyue's product portfolio includes approved formulations such as Lanthanum Carbonate granules, Diquafosol Sodium eye drops, Neostigmine Methylsulfate injection, and Vitamin B1 tablets, alongside a robust pipeline of active pharmaceutical ingredients (APIs) and intermediates.